2nd Annual Digital Therapeutics and Pharma Summit

14 – 15 September 2022 | Vienna

In our constantly evolving healthcare environment, digital medicine has become one of the most significant components. Especially, digital therapeutics and virtual coaching. As their influence on patient care and the industry continues to grow, it is important to harness the innovation and evolution they bring along. What are disruptive digital innovations that could shape the future of the pharma & life-science industry? Are you sure you are ready to face this new era?  Join us at our highly interactive summit to have all your questions answered!

The 2nd Annual Digital Therapeutics and Pharma Summit is a business conference where top digital experts from high-ranking companies within the pharma industry will share their experience and keys to success. This DTx meeting will cover all the current hot topics and challenges regarding digital therapeutics market trends, e-health evolution, global pharmaceutical and regulatory strategies, the boost of technology in patient-centric care, digital health partnerships, mobile health, the power of RWD & RWE, virtual coaching and much more. Moreover, you will gain valuable insight into the future industry`s prospects and opportunities to grow.

This pharma event is the right place to share your ideas with peers, get inspired by the industry’s top players and establish relevant business contacts. Don`t miss your chance to benefit from remarkable networking opportunities with senior-level decision makers!

Hottest topics that will be discussed this annual

  • Digital Therapeutics Market (DTx): Growth, Opportunity and Trends
  • Harness the Power of Real-World Data & Real-World Evidence
  • Mobile health (mHealth) devices: The future of medical technology turning into the new reality
  • Digital biomarkers: Convergence of digital health technologies and biomarkers
  • How to select the right approach in digital health partnerships and bring pharma and DTx together?
  • Not only today matters but also tomorrow. Standardization of digital therapeutics usage
  • COVID-19 impact: The rise of digital health technologies during the pandemic
  • Future Prospect for DTx. Technology which allows us to lead healthier and happier lives

SUMMIT WILL HOST SPEAKERS FROM THE WORLD’S LEADING COMPANIES

Shay WEISS

Director of Novartis Omnichannel Engineering

CASE STUDY DAY 1

Using Data, AI and ML to Accelerate Pharma Omni-Channel Strategy and HCP Engagement

Discover how customer insights, journey maps, and content generation are being powered through a new digital strategy.

• The value AI, MA and Big Data can bring to the HCP engagement
• The digital strategy challenge
• Real life case of “data challenge”
• How do we get there?

Meni STYLIADOU

VP, Distinguished Fellow Data Sciences Institute, Research and Development

CASE STUDY DAY 2

H2O: Creating Ecosystem to Empower Patients to Monitor Their Outcomes in a Standardized Way Through Digital Technologies

It is universally accepted that the patient’s voice matters. However, unless captured in a standardized manner, it is often misunderstood or ignored. The H2O consortium of 26 partners including leading academic hospitals, patient organisations, pharmaceutical companies as well as public authorities came together to do three things:

a. create 'common language' for patients and HCPs through standardized PROs that can be used in clinical practice;
b. partner with technology providers active in digital health to implement this common language in clinical practice in several countries;
c. introduce a governance model to ensure that patients remain in control of their data.

• What does it mean a 'common language' for patients and HCPs and why do we need it?
• How can one create such a 'common language'?
• How does this ecosystem work?
• How would the governance look like? And how does one create the necessary trust?
• What is the value created for the various stakeholders?

Allan Christian SHAW

Corporate Vice President

CASE STUDY DAY 1

Perspectives on Digitalisation of Early Research in Novo Nordisk

Different aspects of the digitalization journey of early research in Novo Nordisk are presented, covering the opportunities for improving innovation and process efficiency, as well as the encountered challenges and learnings, done

• Novo Nordisk’s early research at a glance and why digitalization efforts rapidly became important
• Conducting digital transformation in a highly dynamic research environment
• Examples of impact on innovation, gain of efficiencies and ways of working
• Challenges: From a technology and cultural perspective

Elcie CHAN

EU Commercial Director – Digital Health

CASE STUDY DAY 2

Pharma-Digital Health Partnerships: What Does It Take to Partner to Achieve Success Globally?

There are many Pharma and Digital Health partnerships today, but only a few of these partnerships span multiple regions. What does it take to partner to reach commercial success globally? This presentation will provide a perspective on the key considerations for Global partnership models, with a focus on the U.S. and Europe, and the implications for establishing a successful DTx business across multiple markets.

• The implication of regional differences in Pharma-Digital Health partnership models
• Opportunities and challenges in preparing for Global success
• The impact of organisational structure, culture, and mindset (as individual companies and as partners) on strategy through the execution

Jennie MEDIN

Head Real World Science & Analytics

CASE STUDY DAY 2

Real World Data for Clinical Practice Change

Real World Data (RWD) is a key enabler to move towards personalized engagement with stakeholders with the aim to improve health care and patient outcomes. In this session, we will discuss how RWD can be used to understand patient journeys, focus on medical strategies and personalize customer interactions.

• Real World Data as an enabler
• Clinical Practice Change
• Localized data

It was a pleasure to be part of this conference. Well done to everyone involved – I have heard a lot of good insights.

– Country Lead, Vaccines, Pfizer

We offer to world’s leading companies at our summit

Case Studies

Experience leaders will provide you with lessons learned.

Networking

The chance for market-leading business knowledge networking.

Discussions

All attendees will have a great opportunity to discuss a selection of topics in small groups with their peers.

New Ideas

We are partnering with experienced professionals to provide creative ideas, inspiration, and guidance.

Allan Lloyds Summit mission is to exceed expectations

We are committed to achieving new standards of excellence by providing conference formats that encourages interaction, networking and high class knowledge sharing. With experts, well-supported staff, motivated to deliver quality, Allan Lloyds vision is to be recognized as the global leader in providing high quality business conferences.

What we offer to world’s leading companies

  • Experience-based case studies
  • Round table discussions
  • Impeccable networking opportunities
  • Limited number of seats in the audience ensuring friendly atmosphere
  • No media or press presence

Few photos from our summits

Event programme

Fill your details in the form and we will
send you the whole brochure filled with all details

Your copy of the brochure is prepared.

Inside you will find

  • What keynote speakers will be taking part in the exclusive speaking panel
  • What Case Studies will be discussed by our senior corporate speakers
  • The minute by minute breakdown of the conference